FDA Approved Products

6,646 products with lifecycle intelligence, competitive pressure scores, and patent timelines.

DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5%
dobutamine hydrochloride
LOE Approaching
Pfizer
INJECTION · INJECTABLE
heart failure
1993
NDA
30/100
DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER
dobutamine hydrochloride
LOE Approaching
Baxter
INJECTION · INJECTABLE
heart failure
1993
NDA
30/100
DOBUTAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER
dobutamine in dextrose
LOE Approaching
Pfizer
INJECTION · INJECTABLE
heart failure
1993
NDA
30/100
DOBUTREX
dobutamine hydrochloride
LOE Approaching
Eli Lilly and Company
INJECTION · INJECTABLE
heart failure
1978
NDA
30/100
DOCA
desoxycorticosterone acetate
LOE Approaching
Merck & Co.
INJECTION · INJECTABLE
1939
NDA
30/100
DOCEFREZ
docetaxel
LOE Approaching
Fosun Pharma
INJECTION · INJECTABLE
metastatic breast cancer after failure of prior chemotherapymetastatic non-small cell lung cancer after failure of prior platinum-based chemotherapy+6
2011
NDA
30/100
DOCETAXEL
docetaxel
Peak
Teva
INJECTION · INJECTABLE
metastatic breast cancer after failure of prior chemotherapymetastatic non-small cell lung cancer after failure of prior platinum-based chemotherapy+6
2013
NDA
30/100
DOCETAXEL
docetaxel
LOE Approaching
Pfizer
INJECTION · INJECTABLE
metastatic breast cancer after failure of prior chemotherapymetastatic non-small cell lung cancer after failure of prior platinum-based chemotherapy+6
2011
NDA
30/100
DOCETAXEL
docetaxel
LOE Approaching
Fosun Pharma
INJECTION · INJECTABLE
metastatic breast cancer after failure of prior chemotherapymetastatic non-small cell lung cancer after failure of prior platinum-based chemotherapy+6
2011
NDA
30/100
DOCETAXEL
docetaxel
Peak
Accord Biopharma
INJECTION · INJECTABLE
metastatic breast cancer after failure of prior chemotherapymetastatic non-small cell lung cancer after failure of prior platinum-based chemotherapy+6
2011
NDA
30/100
DOCETAXEL
docetaxel
Peak
Novartis
INJECTION · INJECTABLE
metastatic breast cancer after failure of prior chemotherapymetastatic non-small cell lung cancer after failure of prior platinum-based chemotherapy+6
2011
NDA
30/100
DOCETAXEL
docetaxel
Peak
INJECTION · INJECTABLE
metastatic breast cancer after failure of prior chemotherapymetastatic non-small cell lung cancer after failure of prior platinum-based chemotherapy+6
2012
NDA
30/100
DOCETAXEL
docetaxel
Peak
Pfizer
INJECTION · INJECTABLE
metastatic breast cancer after failure of prior chemotherapymetastatic non-small cell lung cancer after failure of prior platinum-based chemotherapy+6
2014
NDA
30/100
DOLOBID
diflunisal
LOE Approaching
Merck & Co.
ORAL · TABLET
Rheumatoid arthritis
1982
NDA
30/100
DOLOPHINE HYDROCHLORIDE
methadone hydrochloride
LOE Approaching
Hikma
ORAL · SYRUP
severepersistent pain+1
1947
NDA
30/100
DOPAMINE HYDROCHLORIDE
dopamine hydrochloride
LOE Approaching
Medica Corp
INJECTION · INJECTABLE
1981
NDA
30/100
DOPAMINE HYDROCHLORIDE
dopamine hydrochloride
LOE Approaching
Pfizer
INJECTION · INJECTABLE
hemodynamic status in patients in shock
1981
NDA
30/100
DOPAMINE HYDROCHLORIDE
dopamine hydrochloride
LOE Approaching
INJECTION · INJECTABLE
1983
NDA
30/100
DOPAMINE HYDROCHLORIDE
dopamine hydrochloride
LOE Approaching
Baxter
INJECTION · INJECTABLE
1981
NDA
30/100
DOPAMINE HYDROCHLORIDE AND DEXTROSE 5%
dopamine hydrochloride
LOE Approaching
B. Braun
INJECTION · INJECTABLE
1986
NDA
30/100
DOPAMINE HYDROCHLORIDE AND DEXTROSE 5% IN PLASTIC CONTAINER
dopamine hydrochloride
LOE Approaching
B. Braun
INJECTION · INJECTABLE
1986
NDA
30/100
DOPAMINE HYDROCHLORIDE IN DEXTROSE 5%
dopamine hydrochloride
LOE Approaching
Pfizer
INJECTION · INJECTABLE
1995
NDA
30/100
DOPAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER
dopamine hydrochloride in dextrose
LOE Approaching
Pfizer
INJECTION · INJECTABLE
hemodynamic status in patients in shock
1983
NDA
30/100
DOPAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER
dopamine hydrochloride
LOE Approaching
Baxter
INJECTION · INJECTABLE
1987
NDA
30/100
← PreviousPage 59 of 277Next →